Coronavirus protective immunity is short-lasting

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a grant from the European Union's Horizon 2020 research and innovation programme, under the Marie Sklodowska-Curie Actions grant agreement no. 721367 (HONOURs), Amsterdam UMC funding connected to HONOURs, and the Amsterdam UMC PhD scholarship of A.W.D. Edridge.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study is approved by the Medical Ethics Committee of the Amsterdam University Medical Center of the University of Amsterdam, the Netherlands (MEC 07/182). Participation is voluntary and without incentive. Written informed consent of each participant was obtained at enrollment.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes